UUID: ZEDBMBB- A136- “59- BTEE- A9371l7|g0e719ac
TCGA-DB- ABGC- DSA- PR

IIIIIIIIIIIlIlIIIIIIIIIIIIIIIIIIIII II "III“ I IIIIIIIII
IIIIIIIIIIIIIII IIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIII IIIed
IIIIIIIII II I II IIIII I IIII II IIIIII IIIIIII II III I IIIIIIIIIIII II I III

 

IIII
IIII
)IAGNOSIS

A) LEFT AXILLARY CONTENTS, LEVELS I, II AND III:
METASTATIC MELANOMA IN ELEVEN OF TWENTY—SEVEN LYMPH NODES (1 1127).
LARGEST SIZE IS 47.0 MM.
TUMOR IS SUBCAPSULAR AND INTRAPARENCHYMAL. ICCD 0 5
EXTRANODAL EXTENSION IS PRESENT. ")mmmmvw/ NOS ‘8 72 63/ 3

- - . . 61:11; Cdyiﬂﬂuu QWw Mosh
:ntIre report and diagnOSIs completed by J
@j [I £527) ‘ 3

BROSS DESCRIPTION

:A) LEFT AXILLARY CONTENTS LEVEL I, H AND lll — Received is an unoriented fragment of yellow-tan .to red fibrofatty tissue
neasuring 17.3 x 12.1 x 3.2 cm in greatest dimension. The specimen is serially sectioned revealing twenty-seven possible lymph
TOde-like structures ranging in size from 4.7 x 3.2 x 2.1 cm to 0.3 x 0.2 x 0.2 cm in greatest dimension respectively. Three grossly
Jositive appearing possible lymph nodes are noted and representative portions of each are submitted in cassettes A1-A3. Seven
additional possible lymph nodes are bisected and submitted with each one in cassettes A4-A10. The remaining lymph nodes are
submitted in cassettes A11, two possible lymph nodes; A12, three possible lymph nodes; A13, three possible lvmoh nodes; A14,
:hree possible lymph nodes; A15, three possible lymph nodes; A16, three possible lymph nodes.

CLINICAL HISTORY

Melanoma, metastatic to left axilla.
SNOMED CODES

T-C4710, M-87206

‘Some tests reported here may have been developed and performance characteristics determined by These tests have not been
speciﬁcally cleared or approved by the us. Food and Drug Administration."

Released by:

------ END Of REPORT-—----

 

:riter‘u I M lobglth I!”

Diagnu J'jSDIS'C til-’1" "l‘.
T

m rsiteDi. 'an "W “‘I— j—
_-:‘:-—:— I}???

_; DEL-Ming;

 

 

 

 

   

 

 

 

 

 

eavd. _ ”s—’

:0“ H 'IE I I I A‘I,

 

